These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1538900)

  • 1. The Swedish two-county trial of mammographic screening for breast cancer: recent results on mortality and tumor characteristics.
    Tabár L; Fagerberg G; Day NE; Duffy SW
    Pathol Biol (Paris); 1992 Nov; 39(9):846. PubMed ID: 1538900
    [No Abstract]   [Full Text] [Related]  

  • 2. The Swedish Two-County Trial of mammographic screening: cluster randomisation and end point evaluation.
    Duffy SW; Tabar L; Vitak B; Yen MF; Warwick J; Smith RA; Chen HH
    Ann Oncol; 2003 Aug; 14(8):1196-8. PubMed ID: 12881376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties.
    Duffy SW; Tabár L; Chen HH; Holmqvist M; Yen MF; Abdsalah S; Epstein B; Frodis E; Ljungberg E; Hedborg-Melander C; Sundbom A; Tholin M; Wiege M; Akerlund A; Wu HM; Tung TS; Chiu YH; Chiu CP; Huang CC; Smith RA; Rosén M; Stenbeck M; Holmberg L
    Cancer; 2002 Aug; 95(3):458-69. PubMed ID: 12209737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for breast cancer: the Swedish trial.
    Tabàr L; Gad A
    Radiology; 1981 Jan; 138(1):219-22. PubMed ID: 7005939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some random-effects models for the analysis of matched-cluster randomised trials: application to the Swedish two-county trial of breast-cancer screening.
    Nixon R; Prevost TC; Duffy SW; Tabar L; Vitak B; Chen HH
    J Epidemiol Biostat; 2000; 5(6):349-58. PubMed ID: 11234739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computer modelling of the Swedish two county trial of mammographic screening and trade offs between participation and screening interval.
    Fett MJ
    J Med Screen; 2001; 8(1):39-45. PubMed ID: 11373849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update of the Swedish two-county program of mammographic screening for breast cancer.
    Tabàr L; Fagerberg G; Duffy SW; Day NE; Gad A; Gröntoft O
    Radiol Clin North Am; 1992 Jan; 30(1):187-210. PubMed ID: 1732926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Norwegian breast cancer mortality rates and validity of Swedish mammographic studies].
    Zahl PH; Kopjar B; Maehlen J
    Tidsskr Nor Laegeforen; 2001 Jun; 121(16):1928-31. PubMed ID: 11488185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammography screening has little or no effect on breast cancer deaths, Swedish data indicate.
    Mayor S
    BMJ; 2012 Jul; 345():e4847. PubMed ID: 22804922
    [No Abstract]   [Full Text] [Related]  

  • 10. [Undisputable information from a Swedish committee of experts: mammography reduces mortality of breast cancer. Benefits for the 40-49 age group are still not clear].
    Lennholm B
    Lakartidningen; 1992 Dec; 89(49):4297-9. PubMed ID: 1461062
    [No Abstract]   [Full Text] [Related]  

  • 11. Recent results from the Swedish Two-County Trial: the effects of age, histologic type, and mode of detection on the efficacy of breast cancer screening.
    Tabár L; Chen HH; Fagerberg G; Duffy SW; Smith TC
    J Natl Cancer Inst Monogr; 1997; (22):43-7. PubMed ID: 9709274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mammographic screening does not reduce breast cancer mortality].
    Sjönell G; Ståhle L
    Lakartidningen; 1999 Feb; 96(8):904-5, 908-13. PubMed ID: 10089737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammography in symptomatic and asymptomatic patients.
    Stomper PC; Gelman RS
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):611-40. PubMed ID: 2691492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mammographic screening fulfills the requirements of health control].
    Sandelin K
    Lakartidningen; 1999 Mar; 96(9):983-4. PubMed ID: 10093435
    [No Abstract]   [Full Text] [Related]  

  • 15. Results of the Two-County trial of mammography screening are not compatible with contemporaneous official Swedish breast cancer statistics.
    Zahl PH; Gøtzsche PC; Andersen JM; Maehlen J
    Dan Med Bull; 2006 Nov; 53(4):438-40. PubMed ID: 17150148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial.
    Tabár L; Faberberg G; Day NE; Holmberg L
    Br J Cancer; 1987 May; 55(5):547-51. PubMed ID: 3606947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of service screening mammography on population mortality from breast carcinoma.
    Feig SA
    Cancer; 2002 Aug; 95(3):451-7. PubMed ID: 12209736
    [No Abstract]   [Full Text] [Related]  

  • 18. The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up.
    Tabár L; Vitak B; Chen HH; Duffy SW; Yen MF; Chiang CF; Krusemo UB; Tot T; Smith RA
    Radiol Clin North Am; 2000 Jul; 38(4):625-51. PubMed ID: 10943268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in endpoints between the Swedish W-E (two county) trial of mammographic screening and the Swedish overview: methodological consequences.
    Holmberg L; Duffy SW; Yen AM; Tabár L; Vitak B; Nyström L; Frisell J
    J Med Screen; 2009; 16(2):73-80. PubMed ID: 19564519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The National Board of Health and Welfare on mammographic screening: mortality analysis requires completely different methods].
    Rehnqvist N; Rosén M; Karlberg I
    Lakartidningen; 1999 Mar; 96(9):1050-1. PubMed ID: 10093453
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.